MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
MLTX MoonLake Immunotherapeutics
- 52.170
- +0.290+0.56%
Close Dec 20 16:00 ET
- 52.170
- 0.0000.00%
Post 20:01 ET
3.29BMarket Cap-41.08P/E (TTM)
54.100High50.210Low192.79KVolume51.710Open51.880Pre Close10.16MTurnover0.68%Turnover RatioLossP/E (Static)63.06MShares64.98052wk High6.74P/B1.47BFloat Cap37.55052wk Low--Dividend TTM28.21MShs Float64.980Historical High--Div YieldTTM7.50%Amplitude4.250Historical Low52.704Avg Price1Lot Size
MoonLake Immunotherapeutics Stock Analyst Ratings & Price Target
Price Target
Updated: Dec 16, 2024
The average MoonLake Immunotherapeutics stock price target is 75.50 with a max estimate of 104.00 and a min estimate of 55.00
Review MoonLake Immunotherapeutics earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
Updated: Dec 16, 2024